PHS
VTRS icon

PFM Health Sciences’s Viatris VTRS Stock Holding History

PFM Health Sciences’s Portfolio VTRS Stock Details VTRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-4,692,968
Closed -$172M – 125
2018
Q3 		$172M Buy
4,692,968
+212,248
+5% +$7.97M 2.52% 4
2018
Q2 		$162M Sell
4,480,720
-143,359
-3% -$5.62M 2.54% 7
2018
Q1 		$190M Buy
+4,624,079
New +$197M 3.87% 2
2014
Q3 		– Sell
-149,532
Closed -$7.71M – 74
2014
Q2 		$7.71M Buy
+149,532
New +$7.35M 0.15% 61
2013
Q4 		– Sell
-233,887
Closed -$8.93M – 76
2013
Q3 		$8.93M Buy
+233,887
New +$8.23M 0.22% 61

Other funds holding VTRS

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PFM Health Sciences's VTRS Position: Q4 2018 in Review

PFM Health Sciences sold out of Viatris (VTRS) in Q4 2018, closing a stake of 4,692,968 shares — an estimated $172M sold.

PFM Health Sciences first reported a position in VTRS in Q3 2013 and held it in 5 quarters. The position peaked at $190M in Q1 2018. 502 funds tracked by Wall St. Rank hold VTRS as of Q4 2018.

  • PFM Health Sciences reported no remaining Viatris position as of Q4 2018 after selling out during the quarter.
  • PFM Health Sciences sold 4,692,968 Viatris shares in Q4 2018, an estimated $172M.
  • PFM Health Sciences first reported a position in Viatris in Q3 2013 and held it in 5 quarters.
  • PFM Health Sciences's Viatris position peaked at $190M in Q1 2018.
  • 502 funds tracked by Wall St. Rank held Viatris as of Q4 2018.

Based on PFM Health Sciences's 13F filing for Q4 2018, filed 14 Feb 2019.